Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Diabetes Research and Clinical Practice|April 6, 2010
Visceral fat is negatively associated with B-type natriuretic peptide levels in patients with advanced type 2 diabetesTakako Sugisawa, Ichiro Kishimoto, Yoshihiro Kokubo, et al.
Journal of the American College of Cardiology|February 15, 2005
C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarctionTakeshi Soeki, Ichiro Kishimoto, Hiroyuki Okumura, et al.
Endocrinology|October 6, 2007
Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious ratsDaryl O Schwenke, Takeshi Tokudome, Mikiyasu Shirai, et al.
Expert Review of Endocrinology & Metabolism|February 13, 2019
Therapeutic potential of ghrelin in cardiac diseasesIchiro Kishimoto, Takeshi Tokudome, Daryl O Schwenke, et al.
Human Pathology|April 19, 2011
Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network membersHiroyuki Mitomi, Naoshi Fukui, Ichiro Kishimoto, et al.
Endocrinology|April 27, 2012
Ghrelin prevents incidence of malignant arrhythmia after acute myocardial infarction through vagal afferent nervesYuanjie Mao, Takeshi Tokudome, Kentaro Otani, et al.
Endocrinology|July 5, 2008
Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortalityDaryl O Schwenke, Takeshi Tokudome, Ichiro Kishimoto, et al.
Clinical and Experimental Nephrology|May 22, 2014
Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptidesFumiki Yoshihara, Takeshi Tokudome, Ichiro Kishimoto, et al.
Endocrinology|March 22, 2012
One dose of ghrelin prevents the acute and sustained increase in cardiac sympathetic tone after myocardial infarctionDaryl O Schwenke, Takeshi Tokudome, Ichiro Kishimoto, et al.
Pageof 8